首页> 外文期刊>Veterinary Therapeutics >Comparative Adrenocortical Suppression in Dogs with Otitis Externa following Topical Otic Administration of Four Different Glucocorticoid-Containing Medications.
【24h】

Comparative Adrenocortical Suppression in Dogs with Otitis Externa following Topical Otic Administration of Four Different Glucocorticoid-Containing Medications.

机译:局部耳给予四种不同的糖皮质激素药物后,患有外耳炎的狗的比较肾上腺皮质激素抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The safety of using otic formulations is often of concern for practitioners and pet owners alike, with "safe" in this context meaning no adrenocortical suppression. This study evaluated the effect of four glucocorticoid-containing otic formulations on plasma cortisol concentrations, measured by corticotropin stimulation testing (plasma cortisol concentrations before and after corticotropin injection), in dogs presented with otitis externa. Dexamethasone tended to have larger adrenocortical suppression compared with the other three formulations (betamethasone, triamcinolone, and mometasone), but the difference was not statistically significant. The largest difference among the four drugs was observed between dexamethasone and betamethasone (P = .09).
机译:从业人员和宠物主人都经常关注使用耳用制剂的安全性,在这种情况下,“安全”意味着没有肾上腺皮质抑制作用。这项研究评估了四种含糖皮质激素的耳用制剂对患有外耳道炎的犬的血浆皮质醇浓度的影响,该浓度通过促肾上腺皮质激素刺激试验(注射促肾上腺皮质激素前后的血浆皮质醇浓度)进行了测量。与其他三种制剂(倍他米松,曲安西龙和莫米松)相比,地塞米松倾向于具有更大的肾上腺皮质抑制作用,但差异无统计学意义。在地塞米松和倍他米松之间观察到四种药物之间的最大差异(P = .09)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号